Choudhry, Niteesh K <br/><br/>
Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.  [electronic resource] 

 -  American heart journal  Jul 2008 
 - 31-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6744 
<br/><br/><label>Standard No.: </label>10.1016/j.ahj.2008.03.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--economics<br/>Aged<br/>Angiotensin-Converting Enzyme Inhibitors--economics<br/>Cardiovascular Agents--economics<br/>Continuity of Patient Care--economics<br/>Cost Sharing<br/>Drug Costs<br/>Evaluation Studies as Topic<br/>Female<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--economics<br/>Insurance, Pharmaceutical Services--economics<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--diagnosis<br/>Patient Compliance--statistics & numerical data<br/>Patient Selection<br/>Risk Assessment<br/>Secondary Prevention<br/>Sensitivity and Specificity